INS and type 2 diabetes mellitus: Pioglitazone (PIO) is a thiazolidinedione drug and a PPAR γ agonist that acts as an insulin sensitizer, which has been used to treat T2DM for over a decade7 and has been shown to reduce cardiovascular events12.